Morphine Unimedic (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride binds to µ‑opioid receptors in the brain and spinal cord, activating inhibitory pathways that reduce the release of neurotransmitters involved in pain transmission. This results in decreased neuronal excitability and a marked reduction in the perception of pain.

The specific dose and dosing schedule for Morphine Unimedic are determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, renal and hepatic function, and route of administration. No fixed regimen is provided here.

Safety data for Morphine Unimedic in pregnancy and lactation are limited. Opioids can cross the placenta and may be excreted in breast milk, potentially causing respiratory depression in the newborn. Use only if the potential benefit justifies the risk and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Morphine Unimedic is a prototypical µ‑opioid agonist with a well‑characterized efficacy and safety profile. Compared with newer synthetic opioids, it has a longer history of clinical use, predictable pharmacokinetics, and is often chosen for severe pain when rapid onset and reliable analgesia are needed.

Morphine Unimedic should be stored at controlled room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and physical damage. Do not freeze or expose to extreme temperatures.

The medication is supplied as a sterile solution for injection. It can be given epidurally, intramuscularly, or intravenously by a qualified healthcare professional, following aseptic technique and appropriate dosing calculations.

The most critical risks include respiratory depression, severe hypotension, and allergic reactions such as anaphylaxis. These events require immediate medical attention and may be life‑threatening if not recognized and treated promptly.

Morphine Unimedic is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, in those who have taken monoamine oxidase inhibitors within the past 14 days, and in individuals with significant respiratory compromise where opioid use could worsen ventilation.